Retatrutide is a newly developed medication that acts as a potent GLP-1 receptor stimulator. This innovative treatment holds significant hope for managing type 2 diabetes. By replicating the actions of natural GLP-1, Retatrutide enhances insulin secretion and limits glucagon release, leading to improved blood sugar control. Clinical trials have dem